In this clinical white paper, Hey Jane reports on our asynchronous telehealth abortion model for a new era of care.
Now that the Supreme Court has overturned Roe v. Wade, abortion care via mail has become one of the most viable forms of access for most of the country.
Telemedicine abortion—and Hey Jane in particular, as the leading virtual abortion provider—has the opportunity to play an important role in increasing access to safe, high-quality care while addressing the increased demand for care that is currently straining the health care system.
Hey Jane’s unique care model addresses both physical and emotional health needs in a tech-enabled and real-time way that is unparalleled in the industry. While innovative, it is also responsive to what patients want: an intuitive, tech-enabled platform to receive comprehensive, high-quality, safe abortion care.
And yet, this past year we have continued to see baseless, political attacks on medication abortion that are not rooted in fact or science.
That’s why, this International Safe Abortion Day, we are publishing a comprehensive clinical white paper, reporting on the safety, efficacy, and quality of telemedicine abortion care.
Through internal data collection from our existing patient population on care outcomes and external validation through research partnerships, we can definitively say that our model of care is safe, effective, and high quality.
We are proud of the work we’ve done to expand access to safe, effective, and high-quality abortion care during this pivotal moment, and continue to do all that we can to address this important health care need.
Click below to download our clinical white paper Safe, effective, and in-demand: An asynchronous telehealth abortion model for a new era of care.